Back to search

France· FR:64086275

TAMIFLU 6 mg/ml, poudre pour suspension buvable

A medicinal product containing oséltamivir (phosphate d'), registered in France by ROCHE REGISTRATION (ALLEMAGNE), on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedTAMIFLU 6 mg/ml, poudre pour suspensi…ATC—REGISTER NO.FR:64086275PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
OSÉLTAMIVIR (PHOSPHATE D')
Manufacturer
ROCHE REGISTRATION (ALLEMAGNE)
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400922069067
    1 flacon(s) en verre brun avec fermeture de sécurité enfant avec adaptateur avec seringue(s) pour administration orale avec gobelet(s) doseur(s)
    EUR 10.24

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Oséltamivir (phosphate d') in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oséltamivir (phosphate d') products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Bulgaria · Бетафлу
  • Germany · Oseltamivir Hec Pharm, Oseltamivir Stada
  • Estonia · Segosana
  • Spain · Oseltamivir Accord
  • United Kingdom (Northern Ireland) · Oseltamivir, Oseltamivir Accord-Uk
  • Hungary · Segosana
  • Iceland · Ebilfumin, Tamiflu
  • Liechtenstein · Ebilfumin, Tamiflu
  • Lithuania · Segosana
  • Latvia · Segosana
  • Netherlands · Oseltamivir Zentiva, Segosana
  • Norway · Ebilfumin, Tamiflu
  • Poland · Griptavir Med, Oseltamivir Stada
  • Romania · Oseltamivir Accord, Oseltamivir Laropharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ff1e9473-8e8d-4103-a709-b09491648cc3
GET /v1/drugs/ff1e9473-8e8d-4103-a709-b09491648cc3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "64086275",
  "date_amm": "2011-11-28",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/02/222",
  "substance": "OSÉLTAMIVIR (PHOSPHATE D')",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour suspension buvable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about oséltamivir (phosphate d').

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.